Azithromycin and Coronary Events Study
ACES is a clinical trial sponsored by the National Heart, Lung and Blood
Institute. It is being conducted in more than 25 sites with enroll 4,000
volunteer patients.
History:
Some studies suggest that Chlamydia pneumoniae infection may be a
risk factor for heart attacks and other conditions related to heart disease.
This bacteria is spread person to person by sneezing and coughing (unlike a
related bacteria, Chlamydia trachomatis, it is not a sexually transmitted
disease). Studies show that people who have been infected with Chlamydia
pneumoniae in the past have a higher chance of having a heart attack.
Subjects needed:
Anyone with a history of a heart attack, bypass surgery, angioplasty, or a
50% or greater blockage in a coronary artery is eligible for an interview for
the ACES Study with their cardiologist's permission.
Call Ed Mackler, RN, at 401-793-4795, or beep him at
401-785-6331 for a phone
interview.
Back
|
